Enzychem Lifesciences

엔지켐생명과학 · 183490

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$60.7M (₩83.8B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$49.1M

▼ −12.4% YoY

Operating profit · FY2025

−US$10.4M

Loss widened

Net income · FY2025

−US$13.1M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$55.1M(₩76B)	US$56.1M(₩77.4B)	US$49.1M(₩67.8B)
Operating profit	−US$10.4M(−₩14.4B)	−US$9.6M(−₩13.2B)	−US$10.4M(−₩14.3B)
Net income	−US$6.8M(−₩9.4B)	−US$16M(−₩22.1B)	−US$13.1M(−₩18.1B)

Revenue

Operating profit

Net income

ROE

-13.0%

Debt/Eq

7.1%

Op. margin

-21.2%

Net margin

-26.7%

Rev. YoY

▼ −12.4%

Interactive price history isn't here yet. Would you use it?